Economic Evaluation of Tiotropium for Severe Persistent Asthma in Portugal

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1426
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bronchoprotective Tolerance With Indacaterol Is Not Modified by Concomitant Tiotropium in Persistent Asthma

Clinical and Experimental Allergy
AllergyImmunology
2017English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Parameters Associated With Persistent Airflow Obstruction in Chronic Severe Asthma

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2004English

Tiotropium in Children and Adolescents With Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2020English

Utility of Impulse Oscillometry in Patients With Moderate to Severe Persistent Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Persistent Activation of Nuclear Factor–κB Signaling Pathway in Severe Uncontrolled Asthma

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2003English

A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy